You are here:Home-Webinars-Inhaled antimicrobials: Do we get the drug to the bug?

Inhaled antimicrobials: Do we get the drug to the bug?


Speaker: Harm A. W. M. Tiddens, Professor of Pediatric Pulmonology and Allergology, Erasmus Medical Center Sophia Children’s Hospital (Netherlands)

Moderator: Harpal Singh Dhillon, Global Medical Value Director & Founder, AntiBx (UK)

In this webinar, Harm Tiddens will discuss the relation between structural and functional abnormalities of the lung and how this can impact upon the deposition pattern and efficacy of inhaled antibiotics. He will further present the learnings of his research group’s computational fluid dynamic modelling studies and explain why the expectation that inhaled antibiotics result in high concentrations in the lung is unfortunately a misconception.

The presentation will be followed by a Q&A session.


Register now for this live webinar including interactive Q&A session on 28 April, 17:00-18:30 CEST (find your time zone here).

If you have questions or comments, please let us know. Do so by submitting them via the ‘Talk to an expert’ feature or contact us by email: revive@gardp.org.

Register here!
2020-03-02T10:01:05+00:00